As shown in Fig. 5, following intravenous delivery, compared to NP only control group, mice treated with BRCA1 plasmid + NP exhibited reduced trend for development of tumor and the difference was significant at day 14, day 16, day 18, day 20 and day 22; where *p < 0.05. The gene discussed is BRCA1; the disease is neoplasm.